Eur Rev Med Pharmacol Sci 2019; 23 (1 Suppl): 44-47
DOI: 10.26355/eurrev_201903_17348

The role of bacteriotherapy in the prevention of adenoidectomy

I. La Mantia, A. Varricchio, S. Di Girolamo, A. Minni, G.C. Passali, G. Ciprandi

Associazione Italiana Vie Aeree Superiori, Naples, Italy. gio.cip@libero.it


OBJECTIVE: Adenoidectomy is a surgical procedure with potential adverse events. Effective nonsurgical therapy could reduce patient risk and harm. The aim of this study was to evaluate the role of bacteriotherapy to reduce the necessity of adenoid surgery.

PATIENTS AND METHODS: This experimental study was conducted as an open study in 44 children (30 males and 14 females, mean age 4.9 years) who were candidates for adenoidectomy and tympanocentesis as treatment for adenoidal hypertrophy and otitis media with effusion. Twenty-two children were treated with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray, administered as 2 puffs per nostril twice a day for a week for 3 months (study group). The other half of the children was treated with hypertonic saline nasal lavage on the same schedule (control group). Tympanometry and adenoid size assessment were evaluated throughout the intervention period.

RESULTS: In the study group, 6/22 children required surgery, compared to 20/22 children in the study group (p<0.0001). The clinical change in the treated children was a significant reduction of adenoid size (p<0.0001) and improvement of middle ear effusion measured with tympanometry (p<0.0001).

CONCLUSIONS: Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray could significantly reduce the need for adenoid surgery.

Published on: 2019/03/20


Free PDF Download

To cite this article

I. La Mantia, A. Varricchio, S. Di Girolamo, A. Minni, G.C. Passali, G. Ciprandi
The role of bacteriotherapy in the prevention of adenoidectomy

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 1 Suppl
Pages: 44-47
DOI: 10.26355/eurrev_201903_17348